DefinitionThis section has been translated automatically.
Antimalaria drug not approved in Germany, combination preparation of mefloquine (250 mg), sulfadoxine (500 mg) and pyrimethamine (25 mg) per tbl.
Half-lifeThis section has been translated automatically.
4–16 h
You might also be interested in
IndicationThis section has been translated automatically.
Chloroquine-resistant malaria through Pl. falciparum.
Dosage and method of useThis section has been translated automatically.
- Non-immune adults and adults with > 60 kg bw: 3 tbl/day.
- Adults < 60 kg KG and children 10-14 years (31-45 kg): 2 tbl/day
- children 7-9 years (21-30 kg): 1 1/2 dbl/day
- children 4-6 years (11-20 kg): 1 dbl./day
- children < 4 years (5-10 kg): 1/2 dbl/day
Undesirable effectsThis section has been translated automatically.
InteractionsThis section has been translated automatically.
ContraindicationThis section has been translated automatically.
Hypersensitivity to one of the ingredients, blood formation disorders, epilepsy, newborns.
Prof. Dr. med. Peter Altmeyer